Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Spinal Cord Neoplasms 1 Pinealoma 1 Lymphoma, Follicular 1 Glioma 1 Glioblastoma 1 Choroid Plexus Carcinoma 1 Central Nervous System Neoplasms 1

Interventions

Rituximab 52 Cyclophosphamide 49 Lenalidomide 40 fludarabine 24 obinutuzumab 22 Prednisone 18 Magnetic Resonance Spectroscopy 18 Bendamustine Hydrochloride 18 Vincristine 16 fludarabine phosphate 15 Specimen Handling 15 Doxorubicin 15 zanubrutinib 13 Biopsy 12 tazemetostat 10 ibrutinib 10 Whole-Body Irradiation 10 pembrolizumab 9 Peripheral Blood Stem Cell Transplantation 9 venetoclax 8 Mycophenolic Acid 7 Etoposide 7 axicabtagene ciloleucel 6 Radiotherapy 6 CT-P10 6 Therapeutics 5 R-CHOP protocol 5 tisagenlecleucel 4 tafasitamab 4 polatuzumab vedotin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Follicular × perillyl alcohol × 1 year × Clear all

NCT05023018 2026-03-02

NEO100 and High-Grade Meningioma

Neonc Technologies, Inc.

Phase 2 Recruiting

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡